EZZ Life Science Holdings (ASX:EZZ) ROCE % : 20.53% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EZZ Life Science Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 20.53%.

EZZ Life Science Holdings ROCE % Historical Data

The historical data trend for EZZ Life Science Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings ROCE % Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

ROCE %

30.60

16.55

37.55

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			2.34	31.01	29.55	45.75	20.53

EZZ Life Science Holdings ROCE % Calculation

EZZ Life Science Holdings's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	4.911	/	( ( (14.265 - 2.817)	+	(17.641 - 2.935) )	/ 2 )
	=	4.911	/	( (11.448	+	14.706)	/ 2 )
	=	4.911	/	13.077
	=	37.55 %

EZZ Life Science Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	3.08	/	( ( (17.641 - 2.935)	+	(20.297 - 4.999) )	/ 2 )
	=	3.08	/	( ( 14.706	+	15.298 )	/ 2 )
	=	3.08	/	15.002
	=	20.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

EZZ Life Science Holdings (ASX:EZZ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

EZZ Life Science Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines